PerkinElmer Gains China OK for Neonatal Test Analyzer

PerkinElmer, which offers products for human and environmental health, was granted CFDA approval to market a new fully automated analyzing device, the Genetic Screening Processor ® , along with a test that screens for congenital hypothyroidism in newborns. PerkinElmer said the GSP instrument is capable of testing for a wide range of prenatal and neonatal disorders using a spot of dried blood from the infant. More details.... Stock Symbol: (NYSE: PKI) Share this with colleagues: // //